<SEC-DOCUMENT>0001607062-19-000113-index.html : 20190322
<SEC-HEADER>0001607062-19-000113.hdr.sgml : 20190322
<ACCEPTANCE-DATETIME>20190322164022
ACCESSION NUMBER:		0001607062-19-000113
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20190107
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190322
DATE AS OF CHANGE:		20190322

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GENEREX BIOTECHNOLOGY CORP
		CENTRAL INDEX KEY:			0001059784
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820490211
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0731

	FILING VALUES:
		FORM TYPE:		8-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-25169
		FILM NUMBER:		19700365

	BUSINESS ADDRESS:	
		STREET 1:		10102 USA TODAY WAY
		CITY:			MIRAMAR
		STATE:			FL
		ZIP:			33025
		BUSINESS PHONE:		416-364-2551

	MAIL ADDRESS:	
		STREET 1:		10102 USA TODAY WAY
		CITY:			MIRAMAR
		STATE:			FL
		ZIP:			33025
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>gnbt031219form8ka.htm
<DESCRIPTION>FORM 8-K/A
<TEXT>
Document 1 - file: gnbt031219form8ka.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>ex23_1.htm
<DESCRIPTION>EXHIBIT 23.1
<TEXT>
Document 2 - file: ex23_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex99_1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 3 - file: ex99_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ex99_2.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
Document 4 - file: ex99_2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>5
<FILENAME>ex99_3.htm
<DESCRIPTION>EXHIBIT 99.3
<TEXT>
Document 5 - file: ex99_3.htm

</DOCUMENT>
</SEC-DOCUMENT>